The results showed that a high proportion of LC patients with PE had COPD history, adenocarcinoma, advanced TNM stage (III-IV), CVC history, chemotherapy history, high levels of DD and CEA and a low level of PaO2. The gene discussed is CEACAM5; the disease is laryngotracheoesophageal cleft.